Author:
Qubaja Marwan,Marmey Béatrice,Le Tourneau Agnès,Haiat Stéphanie,Cazals-Hatem Dominique,Fabiani Bettina,Diebold Jacques,Marie Jean-Pierre,Audouin Josée,Geissmann Frédéric,Molina Thierry Jo
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine
Reference19 articles.
1. Vardiman JW, Imbert M, Pierre R et al (2001) Chronic myelomonocytic leukemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization classification of tumors: pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 49–52
2. Vardiman JW, Harris NL, Brunning RD (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100:2292–2302
3. Steensma DP, Dewald GW, Lasho TL et al (2005) The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes. Blood 106:1207–1209
4. Bennett JM, Catovsky D, Daniel MT et al (1994) The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French–American–British Cooperative Leukaemia Group. Br J Haematol 87:746–754
5. Fenaux P, Beuscart R, Lai JL et al (1988) Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. J Clin Oncol 6:1417–1424
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献